4.7 Article

Responsiveness and thresholds for clinically meaningful changes in worst pain numerical rating scale for dysmenorrhea and nonmenstrual pelvic pain in women with moderate to severe endometriosis

Journal

FERTILITY AND STERILITY
Volume 115, Issue 2, Pages 423-430

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2020.07.013

Keywords

Endometriosis; pain; numerical rating scale; dysmenorrhea; nonmenstrual pelvic pain

Funding

  1. AbbVie

Ask authors/readers for more resources

The study demonstrated the utility and responsiveness of separate numerical rating scales for assessing worst pain in women with moderate to severe endometriosis-associated pain, and identified initial thresholds for clinically meaningful change.
Objective: To evaluate the utility, responsiveness, and thresholds for clinically meaningful change of a numerical rating scale for worst pain associated with dysmenorrhea (NRS-DYS) and nonmenstrual pelvic pain (NRS-NMPP) in women with moderate to severe endometriosis-associated pain. Design: Analysis of data from two phase III randomized clinical trials (EM-I [NCT01620528] and EM-II [NCT01931670]). Setting: Not applicable. Patient(s): Premenopausal women ages 18-49 years with moderate to severe endometriosis-associated pain. Intervention(s): Participants in both trials were randomized 3:2:2 to receive placebo, elagolix 150 mg once daily, or elagolix 200 mg twice daily for 6 months. Main Outcome Measure(s): NRS-DYS and NRS-NMPP. Result(s): EM-I enrolled 871 women and EM-II enrolled 815 women. For patients with a global impression of improvement at month 3, the least-squares mean change between baseline and month 3 was -3.6 (EM-I and EM-II) for NRS-DYS and -1.9 (EM-I) and -2.0 (EMII) for NRS-NMPP. Standard errors of measurement were 2.99 (EM-I) and 2.86 (EM-II) for NRS-DYS and 1.74 (EM-I) and 1.71 (EM-II) for NRS-NMPP. Baseline half standard deviations were 0.78 (EM-I) and 0.85 (EM-II) for NRS-DYS and 0.92 (EM-I) and 0.96 (EM-II) for NRSNMPP. Conclusion(s): This study demonstrated the utility and responsiveness of separate numerical rating scales to assess worst pain for dysmenorrhea and NMPP in women with moderate to severe endometriosis-associated pain and identified initial thresholds for clinically meaningful change. ((C) 2020 by American Society for Reproductive Medicine.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available